BILL ANALYSIS �
------------------------------------------------------------
|SENATE RULES COMMITTEE | ACR 131|
|Office of Senate Floor Analyses | |
|1020 N Street, Suite 524 | |
|(916) 651-1520 Fax: (916) | |
|327-4478 | |
------------------------------------------------------------
THIRD READING
Bill No: ACR 131
Author: Galgiani (D)
Amended: As introduced
Vote: 21
ASSEMBLY FLOOR : 78-0, 8/21/12 (Consent) - See last page
for vote
SUBJECT : Chronic Obstructive Pulmonary Disease Awareness
SOURCE : Author
DIGEST : This resolution designates November 2012 as
Chronic Obstructive Pulmonary Disease (COPD) Awareness
Month in California; and, encourages public officials and
the citizens of California to increase awareness of the
symptoms of, and the methods of preventing, COPD.
ANALYSIS : This resolution makes the following
legislative findings:
1. COPD, also known as chronic bronchitis and emphysema, is
the third leading cause of death in the United States;
and, its prevalence and death rate is rising.
2. COPD is a chronic and progressive disease that impacts
an estimated 24 million Americans each year; and, many
patients suffering with COPD are not diagnosed until
they have reached an advanced state which often includes
a disabling degree of lung dysfunction.
CONTINUED
ACR 131
Page
2
3. A diagnostic test for COPD, known as spirometry, is
available for office use, allowing early diagnosis of
COPD; and, early diagnosis and management of COPD can
lead to an improved quality of life and self-sufficiency
for patients who received publicly funded benefits,
including Medi-Cal.
4. The "Healthy People 2020" project of the Centers of
Disease Control and Prevention and the National
Institutes of Health concludes that primary care
physicians are in a key position to provide optimal care
to patients with COPD; and, these physicians need to be
trained in the latest methods for diagnosing and
treating the disease.
5. The California COPD Coalition has developed a
comprehensive plan to address COPD in the state,
entitled the "Strategic Plan to Address COPD in
California," which outlines six goal areas, including
the following: prevention, quality of care, public
health infrastructure and advocacy, surveillance,
research, and public education awareness.
FISCAL EFFECT : Fiscal Com.: Yes
SUPPORT : (Verified 8/23/12)
AstraZeneca Pharmaceuticals LP
Boehringer Ingelheim Pharmaceuticals, Inc.
ASSEMBLY FLOOR : 78-0, 8/21/12
AYES: Achadjian, Alejo, Allen, Ammiano, Atkins, Beall,
Bill Berryhill, Block, Blumenfield, Bonilla, Bradford,
Brownley, Buchanan, Butler, Charles Calderon, Campos,
Carter, Cedillo, Chesbro, Conway, Cook, Davis, Dickinson,
Donnelly, Eng, Feuer, Fletcher, Fong, Fuentes, Furutani,
Beth Gaines, Galgiani, Garrick, Gatto, Gordon, Gorell,
Grove, Hagman, Halderman, Hall, Harkey, Hayashi, Hill,
Huber, Hueso, Huffman, Jeffries, Jones, Knight, Lara,
Logue, Bonnie Lowenthal, Ma, Mansoor, Mendoza, Miller,
Mitchell, Monning, Morrell, Nestande, Nielsen, Norby,
Olsen, Pan, Perea, V. Manuel P�rez, Portantino, Silva,
ACR 131
Page
3
Skinner, Smyth, Solorio, Swanson, Torres, Wagner,
Wieckowski, Williams, Yamada, John A. P�rez
NO VOTE RECORDED: Roger Hern�ndez, Valadao
CTW:k 8/23/12 Senate Floor Analyses
SUPPORT/OPPOSITION: SEE ABOVE
**** END ****